日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

同步转移性肾细胞癌治疗选择的实际驱动因素

Almdalal, Tarik; Fahlén, Maja; Harmenberg, Ulrika; Ljungberg, Börje; Lindskog, Magnus

Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients

细胞和分泌组分析揭示了肾细胞癌患者预后的免疫学生物标志物

Tong, Le; Kremer, Veronika; Neo, Shi Yong; Seitz, Christina; Tobin, Nicholas P; Seliger, Barbara; Harmenberg, Ulrika; Colón, Eugenia; Scherman Plogell, Ann-Helén; Liu, Lisa L; Lundqvist, Andreas

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

在接受伊匹木单抗-纳武利尤单抗治疗的真实世界肾细胞癌患者中,基线实验室指标和转移负荷除了能预测IMDC风险外,还能预测生存期。

Kheir, Alaa; Johannsdottir, Berglind; Grönn-Weiss, Alexandra; Liu, Lisa L; Ullén, Anders; Laurell, Anna; Håkansson, Annika; Verbiené, Ingrida; Ullenhag, Gustav; Carlhed, Rickard; Costa Svedman, Fernanda; Lindskog, Magnus; Harmenberg, Ulrika

Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1

肾细胞癌通过下调DNAM-1来逃避NK细胞介导的免疫监视。

Tong, Le; Kremer, Veronika; Neo, Shi Yong; Liu, Yaxuan; Chen, Yi; Wagner, Arnika Kathleen; Yang, Ying; Chen, Ziqing; Seitz, Christina; Tobin, Nicholas Patrick; Ligtenberg, Maarten Alexander; Alici, Evren; Chen, Xinsong; Haglund, Felix; Seliger, Barbara; Harmenberg, Ulrika; Colón, Eugenia; Plogell, Ann-Helén Scherman; Liu, Lisa Lei; Lundqvist, Andreas

Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature

免疫检查点抑制剂引起危及生命的全身炎症综合征:病例报告及文献系统综述

Liu, Lisa L; Skribek, Marcus; Harmenberg, Ulrika; Gerling, Marco

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study

临床T1a期肾细胞癌并非总是无害疾病——一项国家登记研究

Almdalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; Hellström, Mikael; Lindskog, Magnus; Lindblad, Per; Lundstam, Svan; Ljungberg, Börje

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Melflufen 和地塞米松治疗既往接受过大量治疗的复发难治性多发性骨髓瘤

Richardson, Paul G; Oriol, Albert; Larocca, Alessandra; Bladé, Joan; Cavo, Michele; Rodriguez-Otero, Paula; Leleu, Xavier; Nadeem, Omar; Hiemenz, John W; Hassoun, Hani; Touzeau, Cyrille; Alegre, Adrián; Paner, Agne; Maisel, Christopher; Mazumder, Amitabha; Raptis, Anastasios; Moreb, Jan S; Anderson, Kenneth C; Laubach, Jacob P; Thuresson, Sara; Thuresson, Marcus; Byrne, Catriona; Harmenberg, Johan; Bakker, Nicolaas A; Mateos, María-Victoria

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1

Melflufen联合地塞米松治疗复发/难治性多发性骨髓瘤:II期研究O-12-M1的长期生存随访

Bringhen, Sara; Voorhees, Peter M; Plesner, Torben; Mellqvist, Ulf-Henrik; Reeves, Brandi; Sonneveld, Pieter; Byrne, Catriona; Nordström, Eva; Harmenberg, Johan; Obermüller, Jakob; Richardson, Paul G

Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma

血管周围神经纤毛蛋白-1 表达是肾细胞癌生存率提高的独立标志

Eric Morin, Cecilia Lindskog, Martin Johansson, Lars Egevad, Per Sandström, Ulrika Harmenberg, Lena Claesson-Welsh, Elin Sjöberg

Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization

基于两种同步剂量处方的自适应放射外科治疗在关键区域大面积肾细胞癌脑转移瘤中的应用:迈向个性化治疗

Sinclair, Georges; Stenman, M; Benmakhlouf, H; Johnstone, P; Wersäll, P; Lindskog, M; Hatiboglu, M A; Harmenberg, U